Treatment Arm
Visit vs Sp02 Range/Position: 98-100% Non-Supine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 5.2 | ± 18.1 | 0.6 | 0.0 | 218.1 | 2 | 318 |
Final | 275 | 25.8 | ± 55.8 | 1.8 | 0.0 | 419.1 | 26 | 301 |
Treatment Arm vs Sp02 Range/Position: 98-100% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.2 | ± 18.1 | 0.6 | 0.0 | 218.1 | 2 | 318 |
HLSE | 106 | 5.6 | ± 16.1 | 0.5 | 0.0 | 110.1 | - | 106 |
HLSE-O | 105 | 5.6 | ± 25.0 | 0.5 | 0.0 | 218.1 | 1 | 106 |
HLSE-P | 105 | 4.3 | ± 10.0 | 0.6 | 0.0 | 62.6 | 1 | 106 |
Treatment Arm vs Sp02 Range/Position: 98-100% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 25.8 | ± 55.8 | 1.8 | 0.0 | 419.1 | 25 | 300 |
HLSE | 94 | 4.8 | ± 11.7 | 0.8 | 0.0 | 87.8 | 6 | 100 |
HLSE-O | 95 | 62.2 | ± 78.6 | 26.8 | 0.0 | 419.1 | 6 | 101 |
HLSE-P | 86 | 8.6 | ± 28.0 | 0.5 | 0.0 | 215.7 | 13 | 99 |
Age vs Sp02 Range/Position: 98-100% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.2 | ± 18.1 | 0.6 | 0.0 | 218.1 | 2 | 318 |
45-54 years | 52 | 4.6 | ± 9.2 | 0.9 | 0.0 | 42.0 | 1 | 53 |
55-64 years | 139 | 3.8 | ± 11.9 | 0.5 | 0.0 | 110.1 | - | 139 |
65-74 years | 120 | 6.9 | ± 25.4 | 0.5 | 0.0 | 218.1 | 1 | 121 |
75 or older | 5 | 8.2 | ± 17.3 | 0.9 | 0.0 | 39.2 | - | 5 |
Age vs Sp02 Range/Position: 98-100% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 25.8 | ± 55.8 | 1.8 | 0.0 | 419.1 | 25 | 300 |
45-54 years | 42 | 30.4 | ± 61.5 | 1.2 | 0.0 | 248.0 | 7 | 49 |
55-64 years | 117 | 25.2 | ± 60.6 | 1.3 | 0.0 | 419.1 | 10 | 127 |
65-74 years | 112 | 24.5 | ± 48.7 | 2.7 | 0.0 | 225.2 | 7 | 119 |
75 or older | 4 | 30.9 | ± 46.9 | 11.7 | 0.0 | 100.2 | 1 | 5 |
Gender vs Sp02 Range/Position: 98-100% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.2 | ± 18.1 | 0.6 | 0.0 | 218.1 | 2 | 318 |
Male | 232 | 3.8 | ± 15.8 | 0.5 | 0.0 | 218.1 | 2 | 234 |
Female | 84 | 8.9 | ± 22.8 | 0.9 | 0.0 | 132.8 | - | 84 |
Gender vs Sp02 Range/Position: 98-100% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 25.8 | ± 55.8 | 1.8 | 0.0 | 419.1 | 26 | 301 |
Male | 202 | 22.9 | ± 54.3 | 1.4 | 0.0 | 419.1 | 20 | 222 |
Female | 73 | 33.8 | ± 59.4 | 2.9 | 0.0 | 248.0 | 6 | 79 |
Race vs Sp02 Range/Position: 98-100% Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.2 | ± 18.1 | 0.6 | 0.0 | 218.1 | 2 | 318 |
African American or Black | 41 | 14.5 | ± 41.4 | 1.0 | 0.0 | 218.1 | 1 | 42 |
Caucasian | 251 | 3.4 | ± 10.4 | 0.5 | 0.0 | 110.1 | 1 | 252 |
Other | 24 | 8.0 | ± 11.4 | 2.0 | 0.0 | 35.3 | - | 24 |
Race vs Sp02 Range/Position: 98-100% Non-Supine
Final
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 25.8 | ± 55.8 | 1.8 | 0.0 | 419.1 | 25 | 300 |
African American or Black | 34 | 51.6 | ± 73.0 | 7.8 | 0.0 | 234.2 | 6 | 40 |
Caucasian | 219 | 21.8 | ± 52.2 | 1.3 | 0.0 | 419.1 | 18 | 237 |
Other | 22 | 26.2 | ± 51.6 | 5.6 | 0.0 | 225.2 | 1 | 23 |